Plasma apelin and ADMA Levels in patients with essential hypertension (Q39869419)

15 September 2017

title

Plasma apelin and ADMA Levels in patients with essential hypertension (English)

1 reference

15 September 2017

main subject

arterial hypertension

0 references

author name string

Alper Sonmez

1

1 reference

15 September 2017

Gurkan Celebi

2

1 reference

15 September 2017

Gokhan Erdem

3

1 reference

15 September 2017

Serkan Tapan

4

1 reference

15 September 2017

Halil Genc

5

1 reference

15 September 2017

Ilker Tasci

6

1 reference

15 September 2017

Cemal Nuri Ercin

7

1 reference

15 September 2017

Teoman Dogru

8

1 reference

15 September 2017

Selim Kilic

9

1 reference

15 September 2017

Gokhan Uckaya

10

1 reference

15 September 2017

Mahmut Ilker Yilmaz

11

1 reference

15 September 2017

Mehmet Kemal Erbil

12

1 reference

15 September 2017

Mustafa Kutlu

13

1 reference

15 September 2017

publication date

1 May 2010

1 reference

Clinical and Experimental Hypertension

15 September 2017

published in

1 reference

15 September 2017

volume

32

1 reference

15 September 2017

issue

3

1 reference

15 September 2017

page(s)

179-183

1 reference

Apelin, a newly identified adipokine up-regulated by insulin and obesity

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10641960903254505

Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960903254505

Characterization of apelin, the ligand for the APJ receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960903254505

Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960903254505

Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960903254505

Venous dilator effect of apelin, an endogenous peptide ligand for the orphan APJ receptor, in conscious rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960903254505

The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960903254505

Apelin is a novel angiogenic factor in retinal endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960903254505

Modification of the terminal residue of apelin-13 antagonizes its hypotensive action

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960903254505

Vascular effects of apelin in vivo in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960903254505

The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960903254505

Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960903254505

Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960903254505

Plasma apelin is lower in patients with elevated LDL-cholesterol.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960903254505

Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960903254505

Apelin and cardiac function in hemodialyzed patients: possible relations?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960903254505

Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960903254505

ADMA: its role in vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960903254505

Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960903254505

ADMA levels correlate with proteinuria, secondary amyloidosis, and endothelial dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960903254505

Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960903254505

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960903254505

LDL-cholesterol lowering increases plasma apelin in isolated hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960903254505

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960903254505

[(125)I]-(Pyr(1))Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960903254505

Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960903254505

Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960903254505

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960903254505

Short term fluvastatin treatment lowers serum asymmetric dimethylarginine levels in patients with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960903254505

10.3109/10641960903254505

21 January 2018

Identifiers

DOI

1 reference

15 September 2017

1 reference